President and CEO Patrick Kaltenbach said the company delivered an excellent quarter with relatively broad-based growth while capitalizing on improving market demand, with performance particularly strong in Asia and Rest of World.
• Third-quarterRevenuereached $794 million, up about 34% year over year and ahead of roughly $707.5 million expected.
Adjusted net income was USD 93.7 million, or USD 1.23 per diluted share, versus USD 106.0 million, or USD 1.38, in the second quarter and USD 95.7 million, or USD 1.21, a year earlier.
Net income before taxes was USD 81.0 million versus USD 136.4 million, and net income was USD 76.2 million versus USD 106.7 million. Net loss attributable to noncontrolling interests was USD 20.0 million versus USD 6.0 million.
ChiefInvestmentOfficer Matthew McGraner said the results reflect the consistency of the company's strategy, withEarningsthat covered theDividendand a portfolio focused on sectors with durable demand.
The decrease in collaboration revenue was primarily due to reductions in revenue under the 2016 Regeneron Agreement and the ATTR Co/Co. Research and development expenses decreased by USD 11.4 million. Both changes compare the three months ended September 30, 2026 with the same period …
President and CEO Ryan Napierski said revenue came within the guidance range as the company executed on its strategic priorities amid a challenging operating environment.
Operating loss was USD 62.1 million versus USD 12.5 million, and loss before income taxes was USD 45.1 million versus USD 4.3 million. Net loss was USD 26.1 million versus USD 4.5 million, and comprehensive loss was USD 28.5 million.
• Gross proceeds are expected to be $75.0 million beforeUnderwritingdiscounts and offering expenses.
Net income was USD 39.6 million compared with USD 13.0 million, with net income attributable to the company of approximately USD 38.3 million versus approximately USD 12.2 million.